Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan W Partin

Showing results (131-140 of 349) with videos related to

Pageof 35
Sort By:
Urologia Internationalis|November 13, 2010
Is prostate-specific antigen surveillance necessary in men with benign prostate pathology following radical cystoprostatectomy for bladder cancer?Trinity J Bivalacqua, Stacy Loeb, Phillip M Pierorazio, et al.
The Journal of Urology|April 13, 2004
Detection of prostate cancer using serum proteomics pattern in a histologically confirmed populationJinong Li, Nicole White, Zhen Zhang, et al.
The Journal of Urology|November 17, 2009
Validation of the partin nomogram for prostate cancer in a national sampleJames B Yu, Danil V Makarov, Richa Sharma, et al.
Clinical Chemistry|May 25, 2002
Clinical evaluation of the Elecsys total prostate-specific antigen assay on the Elecsys 1010 and 2010 systemsAlexander Haese, Robert T Dworschack, Steven P Piccoli, et al.
BJU International|September 2, 2011
Evolution of the clinical presentation of men undergoing radical prostatectomy for high-risk prostate cancerPhillip M Pierorazio, Ashley E Ross, Misop Han, et al.
Clinical Chemistry|September 27, 2002
Comparison of logistic regression and neural net modeling for prediction of prostate cancer pathologic stageRobert W Veltri, Manisha Chaudhari, M Craig Miller, et al.
The Prostate|April 27, 2011
Treatment decision-making for localized prostate cancer: what younger men choose and whyAbhinav Sidana, David J Hernandez, Zhaoyong Feng, et al.
Oncology (Williston Park, N.Y.)|October 17, 2002
Prostate-specific antigen as a marker of disease activity in prostate cancerAlan W Partin, Gerald E Hanks, Eric A Klein, et al.
The Journal of Urology|November 16, 2004
Impact of surgical delay on long-term cancer control for clinically localized prostate cancerMasood A Khan, Leslie A Mangold, Jonathan I Epstein, et al.
The Journal of Urology|January 23, 2009
Predicting prostate cancer biochemical recurrence using a panel of serum proteomic biomarkersC Nicole Rosenzweig, Zhen Zhang, Xiaer Sun, et al.
Pageof 35

Showing results (131-140 of 349) with videos related to

Sort By:
Pageof 35
Urologia Internationalis|November 13, 2010
Is prostate-specific antigen surveillance necessary in men with benign prostate pathology following radical cystoprostatectomy for bladder cancer?Trinity J Bivalacqua, Stacy Loeb, Phillip M Pierorazio, et al.
The Journal of Urology|April 13, 2004
Detection of prostate cancer using serum proteomics pattern in a histologically confirmed populationJinong Li, Nicole White, Zhen Zhang, et al.
The Journal of Urology|November 17, 2009
Validation of the partin nomogram for prostate cancer in a national sampleJames B Yu, Danil V Makarov, Richa Sharma, et al.
Clinical Chemistry|May 25, 2002
Clinical evaluation of the Elecsys total prostate-specific antigen assay on the Elecsys 1010 and 2010 systemsAlexander Haese, Robert T Dworschack, Steven P Piccoli, et al.
BJU International|September 2, 2011
Evolution of the clinical presentation of men undergoing radical prostatectomy for high-risk prostate cancerPhillip M Pierorazio, Ashley E Ross, Misop Han, et al.
Clinical Chemistry|September 27, 2002
Comparison of logistic regression and neural net modeling for prediction of prostate cancer pathologic stageRobert W Veltri, Manisha Chaudhari, M Craig Miller, et al.
The Prostate|April 27, 2011
Treatment decision-making for localized prostate cancer: what younger men choose and whyAbhinav Sidana, David J Hernandez, Zhaoyong Feng, et al.
Oncology (Williston Park, N.Y.)|October 17, 2002
Prostate-specific antigen as a marker of disease activity in prostate cancerAlan W Partin, Gerald E Hanks, Eric A Klein, et al.
The Journal of Urology|November 16, 2004
Impact of surgical delay on long-term cancer control for clinically localized prostate cancerMasood A Khan, Leslie A Mangold, Jonathan I Epstein, et al.
The Journal of Urology|January 23, 2009
Predicting prostate cancer biochemical recurrence using a panel of serum proteomic biomarkersC Nicole Rosenzweig, Zhen Zhang, Xiaer Sun, et al.
Pageof 35